Diuretic Tablets Recalled

Mylan Pharmaceuticals Inc. is voluntarily recalling more than 28,000 bottles of triamterene and hydrochlorothiazide tablets, USP, 37.5 mg/25 mg, 100-count bottle (NDC 0378-1352-01), according to the July 18, 2018, US Food and Drug Administration (FDA) Enforcement Report.

Recalled are 100-count bottles from lot 2007979 (Exp. 11/20). The bottles were distributed across the United States.

According to the FDA, the tablets are out of specification for stability. Mylan Pharmaceuticals initiated the recall July 9, 2018, but at press time the FDA had not yet issued a recall classification.

Triamterene-hydrochlorothiazide is a prescription diuretic used to treat patients with high blood pressure and fluid retention.

—Jolynn Tumolo

For more Pharmacy Learning Network articles, visit the homepage

To learn about Pharmacy Learning Network Live meetings, click here